Citadel Advisors - TRXADE HEALTH INC ownership

TRXADE HEALTH INC's ticker is MEDS and the CUSIP is 89846A207. A total of 15 filers reported holding TRXADE HEALTH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TRXADE HEALTH INC
ValueSharesWeighting
Q2 2022$20,000
-60.0%
13,195
-27.4%
0.00%
Q1 2022$50,000
-16.7%
18,183
-29.4%
0.00%
Q4 2021$60,000
-10.4%
25,756
+102.8%
0.00%
Q4 2020$67,00012,7000.00%
Other shareholders
TRXADE HEALTH INC shareholders Q4 2020
NameSharesValueWeighting ↓
PERRITT CAPITAL MANAGEMENT INC 135,481$710,0000.39%
HEARTLAND ADVISORS INC 249,200$1,306,0000.08%
B. Riley Wealth Advisors, Inc. 275,650$1,445,0000.05%
Steward Partners Investment Advisory, LLC 482,400$2,527,776,0000.02%
G2 Investment Partners Management LLC 10,000$52,0000.01%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 5,500$29,0000.00%
Renaissance Technologies 110,700$580,0000.00%
Spire Wealth Management 5,000$26,0000.00%
BANK OF AMERICA CORP /DE/ 11$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 1,030$5,0000.00%
View complete list of TRXADE HEALTH INC shareholders